BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8105860)

  • 1. The Wiskott-Aldrich syndrome.
    Peacocke M; Siminovitch KA
    Semin Dermatol; 1993 Sep; 12(3):247-54. PubMed ID: 8105860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X chromosome linked immunodeficiency.
    Schwaber J; Rosen FS
    Immunodefic Rev; 1990; 2(3):233-51. PubMed ID: 1981831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.
    Hendriks RW; De Weers M; Mensink RG; Kraakman ME; Mollee-Versteegde IF; Veerman AJ; Sandkuyl LA; Schuurman RK
    Clin Exp Immunol; 1991 May; 84(2):219-22. PubMed ID: 1709069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of X-linked polymorphic loci as gene markers to track X allele and chimerism in a post-allogeneic peripheral blood stem cell transplant patient with Wiskott-Aldrich syndrome.
    Sasanakul W; Hongeng S; Chuansumrit A; Chaiyaratana W; Pakakasama S; Hathirat P
    J Med Assoc Thai; 2001 Mar; 84(3):379-84. PubMed ID: 11460939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies.
    Scheinman SJ; Pook MA; Wooding C; Pang JT; Frymoyer PA; Thakker RV
    J Clin Invest; 1993 Jun; 91(6):2351-7. PubMed ID: 8099916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of X-chromosome inactivation in bone marrow precursors from carriers of Wiskott-Aldrich syndrome and X-linked severe combined immunodeficiency: evidence that the Wiskott-Aldrich gene is expressed prior to granulocyte-macrophage colony-forming-unit.
    Mantuano E; Candotti F; Giliani S; Parolini O; Lusardi M; Zucchi M; Lanfranchi A; Porta F; Airò P; Albertini A
    Immunodeficiency; 1993; 4(1-4):271-6. PubMed ID: 8167717
    [No Abstract]   [Full Text] [Related]  

  • 7. The Wiskott-Aldrich syndrome.
    Ochs HD
    Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of a new X-linked recessive immunodeficiency syndrome.
    de Saint-Basile G; Le Deist F; Caniglia M; Lebranchu Y; Griscelli C; Fischer A
    J Clin Invest; 1992 Mar; 89(3):861-6. PubMed ID: 1347296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular genetic diagnosis of Wiskott-Aldrich syndrome].
    Orth U; Rosenkranz W; Schwinger E; Holzgreve W; Gal A
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):728-31. PubMed ID: 8413349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3.
    Kwan SP; Lehner T; Hagemann T; Lu B; Blaese M; Ochs H; Wedgwood R; Ott J; Craig IW; Rosen FS
    Genomics; 1991 May; 10(1):29-33. PubMed ID: 1675197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wiskott-Aldrich syndrome: new molecular and biochemical insights.
    Peacocke M; Siminovitch KA
    J Am Acad Dermatol; 1992 Oct; 27(4):507-19. PubMed ID: 1401301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation spectrum in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia: identification of twelve different mutations in the WASP gene.
    Schwartz M; Békássy A; Donnér M; Hertel T; Hreidarson S; Kerndrup G; Stormorken H; Stokland T; Tranebjaerg L; Orstavik KH; Skovby F
    Thromb Haemost; 1996 Apr; 75(4):546-50. PubMed ID: 8743175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of molecular analysis to genetic counseling in the Wiskott-Aldrich syndrome (WAS).
    Notarangelo LD; Candotti F; Parolini O; Mantuano E; Giliani S; Lanfranchi A; Albertini A
    DNA Cell Biol; 1993 Sep; 12(7):645-9. PubMed ID: 8397823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Alu-mediated deletion at Xp11.23 leading to Wiskott-Aldrich syndrome.
    Lutskiy MI; Jones LN; Rosen FS; Remold-O'Donnell E
    Hum Genet; 2002 May; 110(5):515-9. PubMed ID: 12073025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X chromosome inactivation patterns in leucocyte populations of female carriers of Wiskott-Aldrich syndrome with an atypical presentation.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Immunodeficiency; 1993; 4(1-4):267-9. PubMed ID: 8167716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Wiskott-Aldrich syndrome in a hetrozygous woman].
    Tornai I; Kiss A; Laczkó J; Nagy PM
    Orv Hetil; 1989 Mar; 130(13):679-82. PubMed ID: 2657554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
    Andreu N; Matamoros N; Escudero A; Fillat C
    Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.